A Study of the Safety of Gabapentin in a Potential Over-the-Counter Population With Occasional Sleeplessness

Completed · Phase 3 · Has a placebo group

Conditions studied: Transient Insomnia

In brief

The purpose of this study is to assess the safety of gabapentin, as compared to placebo, in a potential over-the-counter population with reports of occasional sleeplessness

Key facts

Study ID

NCT00666575

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

2105

Starts

2004-12-01

Expected to finish

2005-05-01

Last updated by the study team

2021-02-02

Who can join

Age: 12 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects >/= 12 years of age who reported occasional sleeplessness in month prior to screening

You may not qualify if…

• Females who were pregnant or breastfeeding

Where it is running

• Pfizer Investigational Site — Mobile, Alabama, United States
• Pfizer Investigational Site — Phoenix, Arizona, United States
• Pfizer Investigational Site — Beverly Hills, California, United States
• Pfizer Investigational Site — San Francisco, California, United States
• Pfizer Investigational Site — Clearwater, Florida, United States
• Pfizer Investigational Site — DeLand, Florida, United States
• Pfizer Investigational Site — New Port Richey, Florida, United States
• Pfizer Investigational Site — Pembroke Pines, Florida, United States
• Pfizer Investigational Site — West Palm Beach, Florida, United States
• Pfizer Investigational Site — Atlanta, Georgia, United States
• Pfizer Investigational Site — Boise, Idaho, United States
• Pfizer Investigational Site — Boise, Idaho, United States
• Pfizer Investigational Site — Indianapolis, Indiana, United States
• Pfizer Investigational Site — Las Vegas, Nevada, United States
• Pfizer Investigational Site — Las Vegas, Nevada, United States
• Pfizer Investigational Site — Santa Fe, New Mexico, United States
• Pfizer Investigational Site — Nashville, Tennessee, United States
• Pfizer Investigational Site — Austin, Texas, United States
• Pfizer Investigational Site — Fort Worth, Texas, United States
• Pfizer Investigational Site — San Antonio, Texas, United States
• Pfizer Investigational Site — San Antonio, Texas, United States
• Pfizer Investigational Site — Salt Lake City, Utah, United States
• Pfizer Investigational Site — West Jordan, Utah, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.